From February 6, 2024 to March 31, 2024, the company has repurchased 1,796,900 shares, representing 0.29% for CNY 22.86 million. With this, the company has completed the repurchase of 1,796,900 shares, representing 0.29% for CNY 22.86 million under the buyback announced on February 6, 2024.
Maccura Biotechnology Co.Ltd
Equities
300463
CNE1000020H3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.13 CNY | -3.24% | -0.08% | -12.87% |
04-25 | Maccura Biotechnology Co.Ltd Proposes Final Cash Dividend for the Year 2023 | CI |
04-24 | Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.87% | 1.1B | |
-6.26% | 12.11B | |
-4.87% | 8.07B | |
+4.33% | 5.67B | |
+27.42% | 5.48B | |
-9.89% | 4.12B | |
-58.99% | 2.75B | |
+8.97% | 2.62B | |
-5.19% | 2.33B | |
+21.58% | 2.11B |
- Stock Market
- Equities
- 300463 Stock
- News Maccura Biotechnology Co.Ltd
- Tranche Update on Maccura Biotechnology Co.Ltd's Equity Buyback Plan announced on February 6, 2024.